Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer’s disease with cerebrovascular disease

Vascular dementia (VaD) accounts for 15–20% of all dementia cases. It is a syndrome of acquired cognitive impairment with a complex pathophysiological basis. A novel herbal formulation (Sailuotong; SLT) consisting of Panax ginseng C.A Mey, Ginkgo biloba L and Crocus sativus L extracts was developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamacoska, Diana, Chan, Daniel K. Y., Leung, Isabella, Liu, Jian-xun, Brodaty, Henry, Fahey, Paul P., Bensoussan, Alan, Chang, Dennis H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016672/
https://www.ncbi.nlm.nih.gov/pubmed/36920949
http://dx.doi.org/10.1371/journal.pone.0265285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016672/
https://www.ncbi.nlm.nih.gov/pubmed/36920949
http://dx.doi.org/10.1371/journal.pone.0265285

Ejemplares similares